Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5623243 | Alzheimer's & Dementia | 2013 | 14 Pages |
Abstract
Worldwide costs of dementia are enormous and distributed inequitably. There is considerable potential for cost increases in coming years as the diagnosis and treatment gap is reduced. There is also likely to be a trend in low- and middle-income countries for social care costs to shift from the informal to the formal sector, with important implications for future aggregated costs and the financing of long-term care. Only by investing now in research and the development of cost-effective approaches to early diagnosis and care can future societal costs be anticipated and managed.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Anders Wimo, Linus Jönsson, John Bond, Martin Prince, Bengt Winblad, Alzheimer Disease International Alzheimer Disease International,